Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
BMC Medical Education
|
June 26, 2019
Changing medical students' attitudes to and knowledge of deafness: a mixed methods study
Michelle Gilmore, Anna Sturgeon, Clare Thomson, et al.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
July 17, 2014
Safe moving and handling of patients: an interprofessional approach
Matthew P Anderson, Susan Carlisle, Clare Thomson, et al.
Journal of the American Association of Nurse Practitioners
|
November 13, 2013
Centralized resources for nurse practitioners: common early experiences among leaders of six large health systems
Mona N Bahouth, Michael Ackerman, Elizabeth F Ellis, et al.
BMJ Leader
|
October 23, 2024
'Can you have it all?' Exploring perceived gender roles in leadership through the lens of the Chief Pharmaceutical Officer's clinical fellows 2023/24
Ashifa Trivedi, Kaniksha Aggarwal, Amira Chaudry, et al.
Addiction (Abingdon, England)
|
September 14, 2006
Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial
Kirsten C Morley, Maree Teesson, Sophie C Reid, et al.
The International Journal of Pharmacy Practice
|
July 21, 2018
A competency framework for clinical pharmacists and heart failure
Paul Forsyth, Alison Warren, Clare Thomson, et al.
RSC Medicinal Chemistry
|
April 26, 2024
AiZynth impact on medicinal chemistry practice at AstraZeneca
Jason D Shields, Rachel Howells, Gillian Lamont, et al.
Journal of Medicinal Chemistry
|
May 21, 2024
Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
Clare Thomson, Peter Barton, Erin Braybrooke, et al.
Molecular Cancer Therapeutics
|
February 2, 2026
Preclinical to clinical translation of pharmacokinetic-pharmacodynamic relationship in EGFR Exon20Ins mutations: a modelling framework for irreversible inhibitors
Adriana Savoca, Diana Zindel, Radoslaw Polanski, et al.
Cell Reports. Medicine
|
August 26, 2025
AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertions
Aisha M Swaih, Sara Talbot, Adriana Savoca, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
BMC Medical Education
|
June 26, 2019
Changing medical students' attitudes to and knowledge of deafness: a mixed methods study
Michelle Gilmore, Anna Sturgeon, Clare Thomson, et al.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
July 17, 2014
Safe moving and handling of patients: an interprofessional approach
Matthew P Anderson, Susan Carlisle, Clare Thomson, et al.
Journal of the American Association of Nurse Practitioners
|
November 13, 2013
Centralized resources for nurse practitioners: common early experiences among leaders of six large health systems
Mona N Bahouth, Michael Ackerman, Elizabeth F Ellis, et al.
BMJ Leader
|
October 23, 2024
'Can you have it all?' Exploring perceived gender roles in leadership through the lens of the Chief Pharmaceutical Officer's clinical fellows 2023/24
Ashifa Trivedi, Kaniksha Aggarwal, Amira Chaudry, et al.
Addiction (Abingdon, England)
|
September 14, 2006
Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial
Kirsten C Morley, Maree Teesson, Sophie C Reid, et al.
The International Journal of Pharmacy Practice
|
July 21, 2018
A competency framework for clinical pharmacists and heart failure
Paul Forsyth, Alison Warren, Clare Thomson, et al.
RSC Medicinal Chemistry
|
April 26, 2024
AiZynth impact on medicinal chemistry practice at AstraZeneca
Jason D Shields, Rachel Howells, Gillian Lamont, et al.
Journal of Medicinal Chemistry
|
May 21, 2024
Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
Clare Thomson, Peter Barton, Erin Braybrooke, et al.
Molecular Cancer Therapeutics
|
February 2, 2026
Preclinical to clinical translation of pharmacokinetic-pharmacodynamic relationship in EGFR Exon20Ins mutations: a modelling framework for irreversible inhibitors
Adriana Savoca, Diana Zindel, Radoslaw Polanski, et al.
Cell Reports. Medicine
|
August 26, 2025
AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertions
Aisha M Swaih, Sara Talbot, Adriana Savoca, et al.
Page
of 3